- Home
- ZNTL vs HEQ Comparison
ZNTL vs HEQ Comparison
Compare ZNTL & HEQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZNTL
- HEQ
- Stock Information
- Founded
- ZNTL 2014
- HEQ 2011
- Country
- ZNTL United States
- HEQ United States
- Employees
- ZNTL N/A
- HEQ N/A
- Industry
- ZNTL Biotechnology: Pharmaceutical Preparations
- HEQ Investment Managers
- Sector
- ZNTL Health Care
- HEQ Finance
- Exchange
- ZNTL Nasdaq
- HEQ Nasdaq
- Market Cap
- ZNTL 102.2M
- HEQ 118.9M
- IPO Year
- ZNTL 2020
- HEQ N/A
- Fundamental
- Price
- ZNTL $1.23
- HEQ $10.35
- Analyst Decision
- ZNTL Buy
- HEQ
- Analyst Count
- ZNTL 8
- HEQ 0
- Target Price
- ZNTL $8.53
- HEQ N/A
- AVG Volume (30 Days)
- ZNTL 752.0K
- HEQ 43.1K
- Earning Date
- ZNTL 05-20-2025
- HEQ 01-01-0001
- Dividend Yield
- ZNTL N/A
- HEQ 9.78%
- EPS Growth
- ZNTL N/A
- HEQ N/A
- EPS
- ZNTL N/A
- HEQ N/A
- Revenue
- ZNTL $67,425,000.00
- HEQ N/A
- Revenue This Year
- ZNTL N/A
- HEQ N/A
- Revenue Next Year
- ZNTL N/A
- HEQ N/A
- P/E Ratio
- ZNTL N/A
- HEQ N/A
- Revenue Growth
- ZNTL N/A
- HEQ N/A
- 52 Week Low
- ZNTL $1.01
- HEQ $9.08
- 52 Week High
- ZNTL $13.24
- HEQ $11.84
- Technical
- Relative Strength Index (RSI)
- ZNTL 38.08
- HEQ 58.33
- Support Level
- ZNTL $1.33
- HEQ $10.17
- Resistance Level
- ZNTL $1.32
- HEQ $10.50
- Average True Range (ATR)
- ZNTL 0.10
- HEQ 0.16
- MACD
- ZNTL -0.00
- HEQ 0.04
- Stochastic Oscillator
- ZNTL 8.22
- HEQ 74.59
About ZNTL Zentalis Pharmaceuticals Inc.
Zentalis Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing azenosertib (ZN-c3), a potentially first-in-class and best-in-class WEE1 inhibitor for patients with Cyclin E1-positive platinum-resistant ovarian cancer (Cyclin E1+ PROC). The Company manages its operations as a single segment for the purposes of assessing performance and making operating decisions.
About HEQ John Hancock Hedged Equity & Income Fund of Beneficial Interest
John Hancock Hedged Equity & Income Fund is a closed-end management investment company. Its investment objective is to provide total return with a focus on current income and gains and also consisting of long-term capital appreciation. It invests in various sectors such as financials, consumer discretionary, information technology, energy, healthcare, materials, real estate, consumer staples, short-term investments, and others.